Clinical trial Recruiting at 1 site Interventional Ages 20 and up

AI software predicting acute kidney injury in ICU patients

Official title: The Cost-effectiveness of Artificial Intelligence Acute Kidney Injury Prediction Auxiliary Software (Acura AKI)

Run by Huede Healthtech Co., Ltd. · NCT06685367 · Data updated 2026-11-12

This study is testing whether a new AI tool can help doctors predict and prevent kidney problems in ICU patients by alerting them when someone is at high risk.

Quick facts

Study typeInterventional
Ages20 Years and up
SexAll
Enrollment3600 (estimated)
SponsorHuede Healthtech Co., Ltd.
Industry-sponsored
Locations1 site (Taichung)
StatusRecruiting
StartedOctober 17, 2024
Main results expectedSeptember 15, 2025
Study endsSeptember 15, 2025
Registry record updatedNovember 12, 2024
Trial IDNCT06685367 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 20 years old who are admitted to an adult ICU and have a hospital stay of more than 30 hours.

Probably not a fit

Patients who are already diagnosed with acute kidney injury, undergoing hemodialysis, or lack necessary test data will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Acura AKI software utilizes machine learning algorithms to predict the risk of acute kidney injury (AKI) within the next 24 hours for patients in adult intensive care units (ICUs). This prospective randomized clinical trial will assess the effectiveness of the Acura AKI system in improving patient outcomes by enabling early intervention for high-risk patients. Physicians will receive alerts when a patient is identified as high-risk, allowing for timely adjustments in care, including medication and fluid management. The study will evaluate the cost-effectiveness of this approach by analyzing various outcomes such as AKI incidence, dialysis rates, mortality, and hospital stay length.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of acute kidney injury and improve outcomes for critically ill patients.

How similar studies have gone: Other studies have shown promise in using AI for predicting acute kidney injury, but the specific implementation of the Acura AKI system is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Over 20 years old
* Admitted to adult ICU
* Hospital stay of more than 30 hours

Exclusion Criteria:

* Known to have acute kidney injury at enrollment
* Currently undergoing hemodialysis treatment
* No available blood or urine test data
* Pregnant women
* HIV-positive patients
* Those who have not provided informed consent form
* Regarded as unsuitable for inclusion in the trial by the researcher

Where it's running

  • Taichung Veterans General Hospital (TCVGH)
    Taichung, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.